Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/09/2012US20120035202 Rifaximin compositions and method of use
02/09/2012US20120035200 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
02/09/2012US20120035199 Spiroheterocyclic compounds and their uses as therapeutic agents
02/09/2012US20120035198 Antiviral Compounds and Methods of Using Thereof
02/09/2012US20120035197 Novel Use of Fibrates
02/09/2012US20120035196 Carboxylic acid compound
02/09/2012US20120035195 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/09/2012US20120035194 Substituted 2-amino-fused heterocyclic compounds
02/09/2012US20120035193 6-amino-purin-8-one compounds
02/09/2012US20120035192 Selective antagonists of a2a adenosine receptors
02/09/2012US20120035191 Deuterium-enriched pyrimidine compounds and derivatives
02/09/2012US20120035189 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
02/09/2012US20120035188 Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine
02/09/2012US20120035187 Anti-neurodegenerative disease agent
02/09/2012US20120035186 Composition comprising azole fungicide and water soluble metal salt
02/09/2012US20120035185 Method of Using Flibanserin for Neuroprotection
02/09/2012US20120035184 Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase i inhibitors
02/09/2012US20120035183 Cancer Treatment Method
02/09/2012US20120035182 Methods of treatment of chronic pain using eszopiclone
02/09/2012US20120035181 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
02/09/2012US20120035180 Pharmaceutical composition for treating cancer comprising chlorin e6-folic acid conjugate compound and chitosan
02/09/2012US20120035179 Modulators of atp-binding cassette transporters
02/09/2012US20120035178 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
02/09/2012US20120035177 Tablet formulation for p38 inhibitor and method
02/09/2012US20120035176 Analogs of 3-o-acetyl-11-keto-beta-boswellic acid
02/09/2012US20120035175 Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/09/2012US20120035174 Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
02/09/2012US20120035173 Di-substituted amides for enhancing glutamatergic synaptic responses
02/09/2012US20120035172 Purinone Derivatives as HM74A Agonists
02/09/2012US20120035171 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
02/09/2012US20120035170 Novel unsaturated tetracyclic tetrahydrofuran derivatives
02/09/2012US20120035169 Aerosol formulation for the inhalation of beta-agonists
02/09/2012US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
02/09/2012US20120035167 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
02/09/2012US20120035166 Methods of treating a pulmonary bacterial infection using fluoroquinolones
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035163 Novel fused ring compound and use thereof
02/09/2012US20120035162 Process for preparation of high-purity meloxicam and meloxicam potassium salt
02/09/2012US20120035161 Novel Compositions and Methods of Treating Diseases Using the Same
02/09/2012US20120035160 New family of antichagasics derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxide
02/09/2012US20120035159 Substituted isoquinoline derivative
02/09/2012US20120035158 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
02/09/2012US20120035157 2-pyridone derivatives as neutrophil elastase inhibitors and their use
02/09/2012US20120035156 Combination of glyt1 compound with antipsychotics
02/09/2012US20120035155 Indole-2-carboxamide deivative
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035153 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
02/09/2012US20120035152 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
02/09/2012US20120035151 Substituted dihydropyrazolones and their use
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120035149 Prokineticin Receptor Antagonists And Uses Thereof
02/09/2012US20120035148 Ophthalmic compositions and methods for treating ophthalmic conditions
02/09/2012US20120035147 Method for treatment of diseases
02/09/2012US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye
02/09/2012US20120035145 Methods of treating multiple myeloma using melphalan, prednisone and lenalidomide
02/09/2012US20120035144 Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it.
02/09/2012US20120035143 Drug combinations containing pde4 inhibitors and nsaids
02/09/2012US20120035142 Polymorphs of darunavir
02/09/2012US20120035141 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
02/09/2012US20120035140 Carbamoylphosphonates as inhibitors and uses thereof
02/09/2012US20120035139 Gamma-amino-butyric acid derivatives as gabab receptor ligands
02/09/2012US20120035138 Bisphosphonate Formulation
02/09/2012US20120035137 Use of inositol-tripyrophosphate in treating tumors and diseases
02/09/2012US20120035136 Antisense antiviral compounds and methods for treating a filovirus infection
02/09/2012US20120035134 Chemical compounds
02/09/2012US20120035133 Lyophilization Cakes of Proteasome Inhibitors
02/09/2012US20120035132 Boron-containing small molecules
02/09/2012US20120035131 Pyrazoline compounds
02/09/2012US20120035130 Chirally Correct Retinal Cyclodextrin Acetals for Clarifying Skin Complexion
02/09/2012US20120035129 Hydrogel tissue adhesive having reduced degradation time
02/09/2012US20120035128 Polysaccharide derivative and hydrogel thereof
02/09/2012US20120035127 Process for the production of a composition, the composition and the use thereof as food additive
02/09/2012US20120035126 Compounds For Reducing Drug Resistance And Uses Thereof
02/09/2012US20120035125 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
02/09/2012US20120035124 Use of nifuratel to treat infections caused by atopobium species
02/09/2012US20120035123 Combination of compounds for treating or preventing skin diseases
02/09/2012US20120035122 Isoxazoline derivatives as antiparasitic agents
02/09/2012US20120035121 Antibiotic product, use and formulation thereof
02/09/2012US20120035120 Glycolipids as treatment for disease
02/09/2012US20120035119 Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss
02/09/2012US20120035118 Pharmaceutical combinations
02/09/2012US20120035116 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut
02/09/2012US20120035115 Chemical modifications of monomers and oligonucleotides with cycloaddition
02/09/2012US20120035108 Spray base material including low-molecular gelator
02/09/2012US20120035107 Compositions for achieving a therapeutic effect in an anatomical structure
02/09/2012US20120035102 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
02/09/2012US20120035095 Orally administered peptides synergize statin activity
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034644 Identifying material from a breast duct
02/09/2012US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
02/09/2012US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
02/09/2012US20120034317 Prediction of Response to Platinum-Based Therapy
02/09/2012US20120034315 Solid forms of an azocyclic amide
02/09/2012US20120034312 4-isopropyl-3-methylphenol for the treatment of inflammation
02/09/2012US20120034311 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
02/09/2012US20120034307 Aqueous gel formulation and method for inducing topical anesthesia
02/09/2012US20120034306 Polymeric drug delivery systems and processes for producing such systems
02/09/2012US20120034304 Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol
02/09/2012US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
02/09/2012US20120034302 Particulate composition and the method of making the same
1 ... 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 ... 7860